Elementis PLC
27 March 2006
27 March 2005
Elementis plc
Second Phase of Strategic Review
Elementis plc is today announcing the results of the second phase of the Board's
Strategic Review.
In October 2005 the Board, having reviewed the businesses and operations of the
Company, decided to implement a number of changes in order to achieve three key
objectives as follows:
• Improve the base earnings level of the Company
• Reduce the volatility of Chromium earnings
• Focus attention on Specialties, which is the largest and most
profitable business.
Progress so far
Progress has been made in implementing the actions announced in October to
address the first two of these objectives. The reorganisation of certain
corporate and administrative functions in order to improve base earnings,
together with certain actions announced in the first half of 2005, have been
completed and will lead to a reduction in fixed costs in 2006 versus 2005 of
£11.1 million, with a further £1.9 million in 2007. In Chromium the announced
closure of 50% of capacity in the UK, in order to reduce earnings volatility, is
on course to be completed by around the end of the March 2006, and 60% of the
remaining UK production is being sold under twelve month contracts. The Group
has taken some additional actions to stabilise earnings in 2006 by fixing 40% of
its electricity costs and 60% of its gas costs for the year, and hedging
approximately 80% of its US Dollar and Euro cash flows against sterling.
Focusing attention on Specialties
The third objective is to focus attention on Specialties, and this has been the
main theme of the second phase of the Board's Strategic Review. Specialties,
excluding surfactants which are related to the Servo acquisition, already
generates attractive returns, but going forward the Group believes it can
leverage its' portfolio of rheology modifiers and dispersions, which had sales
of £139.7 million in 2005, to increase sales growth rates without compromising
margins. Opportunities in personal care, low solvent thickeners and plastic
additive niches will be pursued via a refocused R&D group to enhanced medium
term performance.
In the near term Specialties will also benefit from further efficiencies
identified during phase two of the Review. Improvements in manufacturing
efficiencies, as well as reductions in selling and administration costs will
reduce costs in 2007 by a further £2.2 million. When combined with savings
announced in October 2005 and changes in US pension benefits to be implemented
by the end of the first half, the Group will benefit from total cost reductions
of £5.3 million in 2007 compared to 2006.
Current Trading
Trading for the first quarter of 2006 has been satisfactory in all categories,
with the coatings markets showing an improvement over 2005.
Commenting on phase two of the Strategic Review, Edward Bramson, Executive
Chairman said:
'Today's announcement is consistent with our strategy of improving the Group's
long term earnings quality and consistency, and we are confident that the
Specialties business will provide an excellent platform for future growth and
cash flow generation. We are now taking steps to improve 2007 earnings
consistency and we intend to provide further updates on segment performance and
the outlook for trading at the time of our Interim announcement.'
- ENDS -
Enquiries:
Elementis plc Tel: +44 (0)1784 227000
Ed Bramson, Chairman
Brian Taylorson, Finance Director
Financial Dynamics Tel: +44 (0)20 7831 3113
Andrew Dowler
Greg Quine
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.